Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M34.5Revenue (TTM) $M0.2Net Margin (%)--Altman Z-Score--
Enterprise Value $M-0.0EPS (TTM) $-0.5Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M17.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NVGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
NVGNRonald Muhlenkamp 2013-03-31 Sold Out -0.03%$1.84 - $9.05
$ 2.01-48%Sold Out0
NVGNRonald Muhlenkamp 2012-12-31 Reduce-0.01%$1.5 - $10.24
$ 2.01-59%Reduce -49.15%18,184
NVGNRonald Muhlenkamp 2012-06-30 Buy 0.02%$1.95 - $2.5
$ 2.01-11%New holding35,757
NVGNRonald Muhlenkamp 2011-12-31 Reduce-0.01%$0.66 - $1.18
$ 2.01136%Reduce -32.42%35,758
NVGNRonald Muhlenkamp 2011-09-30 Add$0.92 - $2.14
$ 2.0151%Add 4.70%52,915
NVGNRonald Muhlenkamp 2011-06-30 Reduce$1.32 - $2.95
$ 2.01-1%Reduce -1.45%50,542
NVGNRonald Muhlenkamp 2011-03-31 Add$0.84 - $3.57
$ 2.0137%Add 1.88%51,287
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVGN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

NVGN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about NVGN:

    News about NVGN:

    Articles On GuruFocus.com
    Novogen (NVGN) Promising Data in Brain Cancer; eFuture Information Technology (EFUT) and NeoPhotonic Mar 04 2015 

    More From Other Websites
    Novogen Submits IND Application to the US FDA for Cantrixil in Ovarian Cancer Aug 14 2016
    Novogen Submits Investigational New Drug (IND) Application to the US FDA For Cantrixil(TM) in... Aug 11 2016
    Novogen Patent Covering Anisina(TM) Has Proceeded to Grant Jun 13 2016
    Novogen Patent Covering Anisina Has Proceeded to Grant Jun 13 2016
    Edison Investment Research Report maintains valuation as Novogen resumes 100% ownership of Cantrixil May 09 2016
    Novogen Provides Update On Development Of Cantrixil May 01 2016
    Novogen Provides Update on Development of Cantrixil May 01 2016
    Cantrixil (TRXE-002-1) Abstract (AACR Annual Meeting 2016) Apr 17 2016
    Novogen Receives R&D Tax Incentive Cash Refund Mar 16 2016
    Novogen Patent Covering Cantrixil And Trilexium Has Proceeded To Grant Feb 19 2016
    Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed Feb 05 2016
    Letter to Shareholders from CEO James Garner Jan 31 2016
    Novogen appoints new CEO Dec 09 2015
    Novogen Appoints Dr James Garner as Chief Executive Officer Dec 09 2015
    NOVOGEN LTD Financials Dec 08 2015
    Novogen Engages Contract Research Organisation to Conduct Cantrixil Phase 1 Clinical Trial Nov 23 2015
    Novogen Patent Covering Cantrixil and Trilexium Accepted in Australia Nov 11 2015
    Preclinical Studies Justify Mode of Delivery and Dosing Regimen for Anisina Nov 10 2015
    Novogen Applies for Long-Term Options Listing on ASX Sep 30 2015
    Novogen Applies for Long-term Options Listing Sep 29 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)